Top Alzheimer’s Research Stories of 2018

January is Alzheimer’s disease awareness month in Canada and Alzheimer’s Society chapters all over Canada are gearing towards raising awareness of the disease among Canadians. It is therefore, an appropriate time to sum up the top research stories on Alzheimer’s disease in 2018, as a reminder of the great work being done to develop treatments to improve the lives of individuals affected by dementia, to help physicians diagnose the disease early, and to identify interventions to reduce the risk of developing the disease.

The symptoms of Alzheimer’s Disease including problems with memory, thinking, behaviour, and inability to carry out daily living activities have been attributed to abnormal protein deposits in the brain, namely amyloid plaques and tau tangles.

In the realm of drug development for Alzheimer’s Disease, 2018 was a bitter-sweet year with some drugs failing to perform in human trials, and other drugs showing some early success.

Drug Trials: The most promising among these are immunotherapies — mainly, antibodies lowering amyloid (Aducanumab) or tau, and BACE inhibitors that reduce the formation of plaques.

Early studies have shown that Aducanumab can decrease amyloid in the brain to levels lower than that required for a PET scan to diagnose the disease. Later studies also confirmed its effectiveness in slowing down the progression of early to moderate disease.

Other anti-amyloid antibodies found beneficial in early Alzheimer’s disease and proceeding to final trials along with Aducanumab include Gantenerumab, Crenezumab, and BAN2401.

LMTM monotherapy, the only antibody targeting the abnormal tau deposits contributing to brain degeneration, has been approved for early trials in humans.

However, BACE inhibitor studies proved disappointing with 3 of their candidates Verubecestat, Atabecestat, and Lanabecestat worsening symptoms in trial participants. Nevertheless, one drug Elenbecestat has progressed to final trials with research community anxiously following their progress.

Bryostatin-1 is the only drug that has shown some potential in helping reverse symptoms in patients with moderate to severe Alzheimer’s, with sustained benefits.

Some drugs approved for other conditions, have been found promising as potential treatment for Alzheimer’s Disease in early studies. These include asthma medication Montelukast, diabetes drug Liraglutide, cancer drug Nilotinib, and epilepsy medication Levetiracetam.

Late 2018 brought the exciting news from University of Texas Southwestern Medical Center about their vaccine that could arm the body to attack Alzheimer’s plaques and tangles before they even start to shut down the brain. They hope to begin testing the vaccines in humans soon.

Researchers in Spain claimed they cleared amyloid from the brain by a plasma exchange process. A related approach of soothing the inflamed aging brain, either with whole plasma or defined fractions from the blood of young adults is in early stage trials.

Early Diagnosis: Efforts have been ongoing to develop tests to help physicians diagnose the disease early, and administer treatment. The much-awaited blood test is just around the corner, along with other non-invasive eye test, saliva test and cognitive test. These tests when available will help physicians identify people at risk of developing the disease up to 5 years ahead of time with accuracy.

Risk Reduction: Increasing recognition that it is easier to prevent dementia than to treat it has paved the way for extensive research in this direction and culminated in a multi-pronged approach to reduce risk. Risk reduction strategies with most evidence include regular physical exercise of moderate intensity (eg. brisk walking), for 30-45 minutes; engaging in life-long learning (learning a skill, language, musical instrument etc.) following a plant-based diet, such as Mediterranean diet; regulating blood pressure (120/80 ideally, or the lowest possible) and volunteering.

I hope that these top stories have helped you understand how you can reduce your risk of dementia and also raise hope among individuals diagnosed with Alzheimer’s disease and their families. Let us hope that 2019 will bring breakthroughs in treatments that may change the course of this devastating illness.

Padmaja Genesh, who holds a bachelor degree in medicine and surgery as well as a bachelor degree in Gerontology, has spent several years teaching and working with health care agencies. A past resident of Red Deer, and a past board member of Red Deer Golden Circle, she is now a Learning Specialist at the Alzheimer Society of Calgary. Please send your comments to padmajaganeshy@yahoo.ca

Just Posted

Report finds many birds in decline but co-operation works to rebuild populations

The bad news is that the populations of more than one-quarter of… Continue reading

Raptors coach Nick Nurse says meeting in the works with Prime Minister Trudeau

Toronto Raptors head coach Nick Nurse says a meeting is in the… Continue reading

Trade, China sure to surface as Trudeau meets Trump, congressional leaders

WASHINGTON — Justin Trudeau is headed back to the White House today… Continue reading

Oil shippers boost security after mysterious attacks in Gulf

DUBAI, United Arab Emirates — A series of attacks on oil tankers… Continue reading

RCMP officer accused of sexual assault could take stand Thursday

Crown prosecutor expected to finish her case in morning

VIDEO: Avengers: Endgame to be re-released with new footage

‘Avatar’ holds global box office record at $2.788 billion, while ‘Endgame’ stands at $2.743 billion…

Quebec’s biggest French school board postpones applying religious symbols law

MONTREAL — Quebec’s largest school board has voted to delay application of… Continue reading

B.C. Conservative MP Mark Warawa dies after cancer diagnosis

OTTAWA — Conservative MP Mark Warawa has died after being diagnosed with… Continue reading

Trump promises help with Canadian detainees in China as Trudeau visits D.C.

WASHINGTON — U.S. President Donald Trump says he will raise the issue… Continue reading

VIDEO: Avengers: Endgame to be re-released with new footage

‘Avatar’ holds global box office record at $2.788 billion, while ‘Endgame’ stands at $2.743 billion…

‘He gets it’: Bowen Byram set to hear name called early at NHL draft

VANCOUVER — Bowen Byram’s bantam coach knew almost immediately the defenceman would… Continue reading

Guardado scores 2 as Mexico beats Canada 3-1

DENVER — Andres Guardado had two goals in the second half, Roberto… Continue reading

Toronto Maple Leafs star Auston Matthews on cover of “NHL 20” video game

Toronto Maple Leafs star forward Auston Matthews will be on the cover… Continue reading

Opinion: Trans Mountain pipeline proceeds should be invested in Alberta

By David Marsden There’s a much-expected sigh of relief now that the… Continue reading

Most Read